Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-31 Purchase |
2025-04-02 6:07 pm |
Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner |
34,775 | $4.2293 | $147,076 | 2,899,326 (Indirect Direct) |
View |
| 2025-03-26 Purchase |
2025-03-27 7:06 pm |
Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner |
37,000 | $5.1062 | $188,931 | 2,864,561 (Indirect Direct) |
View |
| 2025-03-18 Purchase |
2025-03-20 8:02 pm |
Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner |
117,941 | $4.9819 | $587,575 | 2,827,561 (Indirect Direct) |
View |
| 2025-02-26 Purchase |
2025-02-28 4:04 pm |
Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner |
336,756 | $4.2734 | $1,439,087 | 2,709,620 (Indirect Direct) |
View |
| 2024-07-30 Purchase |
2024-07-31 4:19 pm |
Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner |
85,800 | $7.15 | $613,470 | 2,372,864 (Indirect Direct) |
View |
| 2024-07-17 Purchase |
2024-07-18 9:16 pm |
Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner |
216,264 | $8.2569 | $1,785,662 | 2,287,064 (Indirect Direct) |
View |
| 2024-02-07 Purchase |
2024-02-09 5:51 pm |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
100,000 | $1.35 | $135,000 | 103,334 (Indirect Direct) |
View |
| 2024-02-07 Purchase |
2024-02-09 5:50 pm |
Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director |
130,000 | $1.35 | $175,500 | 130,000 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-18 6:54 pm |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
6,201 | $1.5206 | $9,429 | 47,674 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-25 Option Award |
2025-02-27 4:05 pm |
N/A 2035-02-24 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
91,875 | $0 | 120,864 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-27 4:05 pm |
N/A 2035-02-24 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer |
56,875 | $0 | 56,875 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-27 4:05 pm |
N/A 2035-02-24 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER |
56,875 | $0 | 63,442 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-27 4:05 pm |
N/A 2035-02-24 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR |
175,000 | $0 | 246,614 (Direct) |
View |
| 2025-02-25 Option Award |
2025-02-27 4:05 pm |
N/A 2035-02-24 |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER |
56,875 | $0 | 68,075 (Direct) |
View |
| 2024-08-02 Option Award |
2024-08-06 4:10 pm |
N/A 2034-08-01 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer |
44,010 | $0 | 44,010 (Direct) |
View |
| 2024-08-02 Option Award |
2024-08-06 4:10 pm |
N/A 2034-08-01 |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER |
62,083 | $0 | 62,083 (Direct) |
View |
| 2024-08-02 Option Award |
2024-08-06 4:09 pm |
N/A 2034-08-01 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER |
43,458 | $0 | 43,458 (Direct) |
View |
| 2024-08-02 Option Award |
2024-08-06 4:09 pm |
N/A 2034-08-01 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
64,394 | $0 | 64,394 (Direct) |
View |
| 2024-08-02 Option Award |
2024-08-06 4:08 pm |
N/A 2034-08-01 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2024-07-18 9:16 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner |
0 | $0 | 2,207,976 (Indirect) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:50 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:49 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:48 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Hong Soo Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:48 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:47 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:46 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:45 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:44 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:43 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director |
13,820 | $0 | 13,820 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:43 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Kiss Szilard Director |
21,040 | $0 | 21,040 (Direct) |
View |
Ownership |
2024-06-20 4:42 pm |
N/A 2026-11-01 |
Adverum Biotechnologies Inc. | ADVM | Kiss Szilard Director |
0 | $0 | 20,750 (Direct) |
View |
| 2023-10-03 Option Award |
2024-03-12 7:07 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER |
85,000 | $0 | 85,000 (Direct) |
View |
| 2023-10-03 Option Award |
2024-03-12 7:06 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
130,000 | $0 | 130,000 (Direct) |
View |
| 2023-10-03 Option Award |
2024-03-12 7:05 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR |
315,000 | $0 | 315,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:33 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER |
400,000 | $0 | 400,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:31 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR |
1,104,200 | $0 | 1,104,200 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:29 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER |
350,000 | $0 | 350,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:27 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-11-03 Option Award |
2023-11-06 7:54 pm |
N/A 2033-11-02 |
Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director |
80,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2023-11-06 7:52 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director |
0 | $0 | 0 (Direct) |
View |